We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Deltex Medical Group Plc | LSE:DEMG | London | Ordinary Share | GB0059337583 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.125 | 0.11 | 0.14 | 0.125 | 0.125 | 0.13 | 199,650 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electromedical Apparatus | 1.78M | -1.28M | -0.0007 | -1.71 | 2.22M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/6/2015 23:37 | kas, No idea but Atlas shrugged. | serratia | |
23/6/2015 21:13 | Gavapentin, I have one question for you: Who is John Galt? ;) | kasman | |
23/6/2015 18:30 | --->FEBRUARY 30TH I missed your posts. Why did you delete them? Regards, THE COUNT! | the count | |
23/6/2015 10:33 | Feb Thank you and agreed. | mrc2u | |
23/6/2015 10:30 | Remember Ewan was FD before becoming CEO. | doglover2003 | |
23/6/2015 10:12 | mrC2u, OK, I've removed everything. Still, I believe it is a surprisingly low key appointment. | february 30th | |
23/6/2015 10:03 | Feb - think you're reading too much into it - he looks like a corporate type who uses a one-man company for tax planning purposes to me. | supernumerary | |
23/6/2015 09:29 | Feb - yes, I thought it was rather low-key. Could mean they're focusing on conserving their cash rather than raising more of it, which would only be a good thing. | supernumerary | |
15/6/2015 10:15 | BigT and Ramnik - agree with you. It is crazy how much variation there is. Once patient level costing is available in ALL hospitals - i.e. the entire cost for an operation inc. staff, consumables, loS etc, then there is a hope of maximising ops in the good places and reducing in the bad ones. Whilst some uniformity should be easy to achieve (e.g. hip prostheses), it is difficult to compare apples with apples in the NHS e.g. in the big teaching hospital, the hips that are operated upon are harder (the ISTC/Private providers will not do them), the patient’s have more comorbidities and social problems as wealth=health, so LoS is longer, and the trainee surgeons/anaesthetis Also - whilst “bad” places perhaps should be shut down, they might be a regional trauma centre so they need a variety of skillsets or the trauma cannot be treated. Thus those hospitals need “nuturing̶ | gavapentin | |
14/6/2015 17:02 | It has been known for a long time that there are huge differences in unit costs for various surgery type across NHS hospitals. Unfortunately, no govt nor NHS leadership has managed to get the 'stick' out. i.e. close down units that cost multiples of more efficient units and transfer the funds to the efficient units A threat of closure would get minds focused. But unfortunately they know govt nor nhs leadership has the guts to start closing units. Instead they just increase the waiting list for surgeries. | ramnik007 | |
14/6/2015 02:07 | Gav, What do you think of the Lord Carter of Coles interim report regarding operational productivity within the NHS? I see there is an article on page 4 of the Financial Times dated 8th June 2015 about productivity and cost variation. The article states: 'From next April the Care Quality Commission, the hospital inspectorate, will judge each institution not only on the quality of care but on its "use of resources", according to Jeremy Hunt, health secretary.' (BigTs view - will the hospitals take any notice??) At the end of the article it states: 'The cost of standard clinical procedures can also vary enormously between hospitals. Research commissioned by the FT last year found taxpayers were paying up to five times more for operations in some NHS hospitals compared with others.' | bigt20 | |
11/6/2015 10:43 | ECLAIR - I am not being picky - it was not a trial. It is a very important difference and possibly deliberate or if not, definitely naive. The "dig" in saying oh dear, is simply a function of having been repeatedly slated for stating FACTS (when they don't fit the agenda of the other poster, which is usually a ramping agenda). As Dozey correctly points out, trying to tease what is down to the ODM vs the ERAS program is impossible although historic trials would suggest not a great deal. Again, as he says, this is possibly immaterial, hospitals/companies are likely to adopt the "whole package" unless a randomised trial is completed within the USA of ERAS plus ODM vd ERAS without ODM. That is unlikely in the near future but will be done in due course as ODM does come with a price tag and every bit saved is more profit. A few years of possible big sales ahead though in interim and who knows...maybe more thereafter (or less!) | gavapentin | |
09/6/2015 16:48 | Here's the crux of the findings: 18.5% of patients discharged on day two after surgery (historic control: 1.7% of patients discharged on day two) 25% reduction in both median and mean length of stay 80% reductions in both post-operative cardiac events and wound infections. Of course we don't know how much is down to ODM, but if I were involved in the huge US health insurance set-up and counting the dollars those findings would ring a few bells. (Also thinking of the law suits if my hospital lagged behind.) Having been completely fed up with this jam the day after tomorrow story, my finger is no longer over the sell button and back to hope! | dozey1 | |
09/6/2015 13:19 | gav, why be so picky - we all know what Arf meant. Please leave your 'oh dears' for the blatant rampers. | eclair | |
09/6/2015 11:07 | The doctors presenting the results seemed happy. OK, it was a trial of a_protocol_including | arf dysg | |
09/6/2015 10:50 | 7520.....oh dear.... Not a trial. One part of an ERAS program. But good headline for company and a step in the right direction in USA. | gavapentin | |
09/6/2015 09:26 | At last a clear no-nonsense headline not obfuscated by medical technical jargon. | goodgrief | |
09/6/2015 08:51 | If anyone complains that ODM has no recent trials, this should squash that complaint. | arf dysg | |
09/6/2015 08:49 | And about time too. This is exactly the kind of statement from a US hospital that we've been waiting for. | eclair | |
09/6/2015 07:40 | Appears to be a very positive result unless I have missed something. | amt | |
09/6/2015 07:37 | Let's hope the positive outcomes enables faster adoption across multiple surgery types across more hospitals. | ramnik007 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions